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INTRODUCTION & OBJECTIVES: Aim of our study was to evaluate
long term clinicopathological outcomes in intermediate to high risk
patients but otherwise clinically localized prostate cancer (PCa) and
Gleason score (GS)≥7 treated by anterograde radical prostatectomy
(ARP), and to analyze the well known predictors of progression in this
cohort 
MATERIAL & METHODS: We prospectively recruited 183 patients
with GS≥7, preoperative PSA≥10 ng/ml and clinically localized PCa 
undergoing to ARP from 2000 to 2010,selected from our institutional
database of 1328 patients.Clinico-pathological features were 
evaluated. Survival analysis were performed using the Kaplan Meier
method. Logistic regression was used to determine predictors of
unfavorable disease 
RESULTS: 51.3% of patients presented pathological GS 7,while 
48.7% had GS 8-10. We obtained a prevalence of extracapsular
extension (79.8%) at final pathological examination. Incidence of
positive surgical margins was 20.7% with a prevalence of pT3-4 
(86.9%), 7.1% with concomitant lymphnode involvement. The mean
follow up was 39.1 months (median 31.5,range 6-119). The 
progression free survival rate for all patients was 64.8 and 55.1% at 3
and 5 years respectively.Above all 25.7% of patients had biochemical
recurrence (BCR) and mean time to biochemical failure was 13 months
(median 11,range 3-56). Of 102 patients with bioptic GS 7,in 79.4% it 
was confirmed at the final pathological specimen,while in 20.6% there
was an higher pathological GS (8-10). A statistically significant 
difference was found in BCR-free survival comparing the 5-year 
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survival rates for GS and pTNM.For those with pathologic GS 7 and 8-
10,BCR free survival rates were 63.9 and 45.4% respectively
(p=0.015), while for pT2, pT3a and pT3b were 78.3, 68.6 and 28.9%
respectively (p0.05).Bioptic and pathological GS,pTNM,surgical margin
status and lymphnode involvement demonstrated to be predictors of
unfavorable disease at univariate logistic regression. On the contrary
at the multivariate logistic regression preop PSA level,bioptic and
pathological GS and surgical margin status had no statistically
significant impact on BCR-free survival.The multivariate Cox model
showed tumor stage as the only independent prognostic factor for
BCR,especially seminal vesicle invasion to be the only independent
prognostic factor (p=0.018) 
CONCLUSIONS: Cancer specific survival in our study indicated that 
selected patients with intermediate to high risk PCa who undergo RP
can experience a survival benefit,even when NS surgery was adopted
through men with unfavorable disease fared poorly 
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